PubMed:12738769
Annnotations
PubMed_ArguminSci
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 183-440 | DRI_Challenge | denotes | Amyloid-beta (Abeta) is a major constituent of the neuritic plaque found in the brain of Alzheimer's disease patients, and a great deal of evidence suggests that the neuronal loss that is associated with the disease is a consequence of the actions of Abeta. |
| T2 | 441-686 | DRI_Outcome | denotes | In the past few years, it has become apparent that activation of c-Jun N-terminal kinase (JNK) mediates some of the effects of Abeta on cultured cells; in particular, the evidence suggests that Abeta-triggered JNK activation leads to cell death. |
| T3 | 687-909 | DRI_Approach | denotes | In this study, we investigated the effect of intracerebroventricular injection of Abeta(1-40) on signaling events in the hippocampus and on long term potentiation in Schaffer collateral CA1 pyramidal cell synapses in vivo. |
| T4 | 910-1154 | DRI_Outcome | denotes | We report that Abeta(1-40) induced activation of JNK in CA1 and that this was coupled with expression of the proapoptotic protein, Bax, cytosolic cytochrome c, poly-(ADP-ribose) polymerase cleavage, and Fas ligand expression in the hippocampus. |
| T5 | 1155-1326 | DRI_Approach | denotes | These data indicate that Abeta(1-40) inhibited expression of long term potentiation, and this effect was abrogated by administration of the JNK inhibitor peptide, D-JNKI1. |
| T6 | 1327-1426 | DRI_Outcome | denotes | In parallel with these findings, we observed that Abeta-induced changes in caspase-3 activation and |
| T7 | 1454-1525 | DRI_Outcome | denotes | labeling staining in neuronal cultured cells were inhibited by D-JNKI1. |
| T8 | 1526-1798 | DRI_Challenge | denotes | We present evidence suggesting that interleukin (IL)-1beta plays a significant role in mediating the effects of Abeta(1-40) because Abeta(1-40) increased hippocampal IL-1beta and because several effects of Abeta(1-40) were inhibited by the caspase-1 inhibitor Ac-YVAD-CMK. |
| T9 | 1799-1962 | DRI_Outcome | denotes | On the basis of our findings, we propose that Abeta-induced changes in hippocampal plasticity are likely to be dependent upon IL-1beta-triggered activation of JNK. |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-182 | Sentence | denotes | Activation of the c-Jun N-terminal kinase signaling cascade mediates the effect of amyloid-beta on long term potentiation and cell death in hippocampus: a role for interleukin-1beta? |
| T2 | 183-440 | Sentence | denotes | Amyloid-beta (Abeta) is a major constituent of the neuritic plaque found in the brain of Alzheimer's disease patients, and a great deal of evidence suggests that the neuronal loss that is associated with the disease is a consequence of the actions of Abeta. |
| T3 | 441-686 | Sentence | denotes | In the past few years, it has become apparent that activation of c-Jun N-terminal kinase (JNK) mediates some of the effects of Abeta on cultured cells; in particular, the evidence suggests that Abeta-triggered JNK activation leads to cell death. |
| T4 | 687-909 | Sentence | denotes | In this study, we investigated the effect of intracerebroventricular injection of Abeta(1-40) on signaling events in the hippocampus and on long term potentiation in Schaffer collateral CA1 pyramidal cell synapses in vivo. |
| T5 | 910-1154 | Sentence | denotes | We report that Abeta(1-40) induced activation of JNK in CA1 and that this was coupled with expression of the proapoptotic protein, Bax, cytosolic cytochrome c, poly-(ADP-ribose) polymerase cleavage, and Fas ligand expression in the hippocampus. |
| T6 | 1155-1326 | Sentence | denotes | These data indicate that Abeta(1-40) inhibited expression of long term potentiation, and this effect was abrogated by administration of the JNK inhibitor peptide, D-JNKI1. |
| T7 | 1327-1525 | Sentence | denotes | In parallel with these findings, we observed that Abeta-induced changes in caspase-3 activation and TdT-mediated dUTP nick-end labeling staining in neuronal cultured cells were inhibited by D-JNKI1. |
| T8 | 1526-1798 | Sentence | denotes | We present evidence suggesting that interleukin (IL)-1beta plays a significant role in mediating the effects of Abeta(1-40) because Abeta(1-40) increased hippocampal IL-1beta and because several effects of Abeta(1-40) were inhibited by the caspase-1 inhibitor Ac-YVAD-CMK. |
| T9 | 1799-1962 | Sentence | denotes | On the basis of our findings, we propose that Abeta-induced changes in hippocampal plasticity are likely to be dependent upon IL-1beta-triggered activation of JNK. |
Glycosmos6-MAT
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 140-151 | http://purl.obolibrary.org/obo/MAT_0000114 | denotes | hippocampus |
| T2 | 263-268 | http://purl.obolibrary.org/obo/MAT_0000098 | denotes | brain |
| T3 | 808-819 | http://purl.obolibrary.org/obo/MAT_0000114 | denotes | hippocampus |
| T4 | 1142-1153 | http://purl.obolibrary.org/obo/MAT_0000114 | denotes | hippocampus |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 183-190 | HP_0011034 | denotes | Amyloid |
| T2 | 234-249 | HP_0100256 | denotes | neuritic plaque |
| T3 | 272-291 | HP_0002511 | denotes | Alzheimer's disease |
| T4 | 314-318 | HP_0000365 | denotes | deal |
| T5 | 349-362 | HP_0002529 | denotes | neuronal loss |
UseCases_ArguminSci_Discourse
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-182 | DRI_Approach | denotes | Activation of the c-Jun N-terminal kinase signaling cascade mediates the effect of amyloid-beta on long term potentiation and cell death in hippocampus: a role for interleukin-1beta? |
| T2 | 183-440 | DRI_Challenge | denotes | Amyloid-beta (Abeta) is a major constituent of the neuritic plaque found in the brain of Alzheimer's disease patients, and a great deal of evidence suggests that the neuronal loss that is associated with the disease is a consequence of the actions of Abeta. |
| T3 | 441-686 | DRI_Outcome | denotes | In the past few years, it has become apparent that activation of c-Jun N-terminal kinase (JNK) mediates some of the effects of Abeta on cultured cells; in particular, the evidence suggests that Abeta-triggered JNK activation leads to cell death. |
| T4 | 687-909 | DRI_Approach | denotes | In this study, we investigated the effect of intracerebroventricular injection of Abeta(1-40) on signaling events in the hippocampus and on long term potentiation in Schaffer collateral CA1 pyramidal cell synapses in vivo. |
| T5 | 910-1154 | DRI_Outcome | denotes | We report that Abeta(1-40) induced activation of JNK in CA1 and that this was coupled with expression of the proapoptotic protein, Bax, cytosolic cytochrome c, poly-(ADP-ribose) polymerase cleavage, and Fas ligand expression in the hippocampus. |
| T6 | 1155-1326 | DRI_Approach | denotes | These data indicate that Abeta(1-40) inhibited expression of long term potentiation, and this effect was abrogated by administration of the JNK inhibitor peptide, D-JNKI1. |
| T7 | 1327-1426 | DRI_Outcome | denotes | In parallel with these findings, we observed that Abeta-induced changes in caspase-3 activation and |
| T8 | 1427-1453 | Token_Label.OUTSIDE | denotes | TdT-mediated dUTP nick-end |
| T9 | 1454-1525 | DRI_Outcome | denotes | labeling staining in neuronal cultured cells were inhibited by D-JNKI1. |
| T10 | 1526-1798 | DRI_Challenge | denotes | We present evidence suggesting that interleukin (IL)-1beta plays a significant role in mediating the effects of Abeta(1-40) because Abeta(1-40) increased hippocampal IL-1beta and because several effects of Abeta(1-40) were inhibited by the caspase-1 inhibitor Ac-YVAD-CMK. |
| T11 | 1799-1962 | DRI_Outcome | denotes | On the basis of our findings, we propose that Abeta-induced changes in hippocampal plasticity are likely to be dependent upon IL-1beta-triggered activation of JNK. |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 83-90 | Disease | denotes | amyloid | http://purl.obolibrary.org/obo/MONDO_0019065 |
| T2 | 183-190 | Disease | denotes | Amyloid | http://purl.obolibrary.org/obo/MONDO_0019065 |
| T3 | 272-291 | Disease | denotes | Alzheimer's disease | http://purl.obolibrary.org/obo/MONDO_0004975 |
NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 140-151 | OrganismTaxon | denotes | hippocampus | 72046 |
| T2 | 808-819 | OrganismTaxon | denotes | hippocampus | 72046 |
| T3 | 1142-1153 | OrganismTaxon | denotes | hippocampus | 72046 |
Anatomy-MAT
| Id | Subject | Object | Predicate | Lexical cue | mat_id |
|---|---|---|---|---|---|
| T1 | 140-151 | Body_part | denotes | hippocampus | http://purl.obolibrary.org/obo/MAT_0000114 |
| T2 | 263-268 | Body_part | denotes | brain | http://purl.obolibrary.org/obo/MAT_0000098 |
| T3 | 808-819 | Body_part | denotes | hippocampus | http://purl.obolibrary.org/obo/MAT_0000114 |
| T4 | 1142-1153 | Body_part | denotes | hippocampus | http://purl.obolibrary.org/obo/MAT_0000114 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 140-151 | Body_part | denotes | hippocampus | http://purl.obolibrary.org/obo/UBERON_0001954|http://purl.obolibrary.org/obo/UBERON_0002421|http://purl.obolibrary.org/obo/UBERON_0002961 |
| T4 | 243-249 | Body_part | denotes | plaque | http://purl.obolibrary.org/obo/UBERON_0016482 |
| T5 | 263-268 | Body_part | denotes | brain | http://purl.obolibrary.org/obo/UBERON_0000955|http://purl.obolibrary.org/obo/UBERON_6110636 |
| T7 | 808-819 | Body_part | denotes | hippocampus | http://purl.obolibrary.org/obo/UBERON_0001954|http://purl.obolibrary.org/obo/UBERON_0002421|http://purl.obolibrary.org/obo/UBERON_0002961 |
| T10 | 877-891 | Body_part | denotes | pyramidal cell | http://purl.obolibrary.org/obo/CL_0000598 |
| T11 | 892-900 | Body_part | denotes | synapses | http://purl.obolibrary.org/obo/GO_0045202 |
| T12 | 1142-1153 | Body_part | denotes | hippocampus | http://purl.obolibrary.org/obo/UBERON_0001954|http://purl.obolibrary.org/obo/UBERON_0002421|http://purl.obolibrary.org/obo/UBERON_0002961 |
HP-phenotype
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 234-249 | Phenotype | denotes | neuritic plaque | HP:0100256 |
| T2 | 272-291 | Phenotype | denotes | Alzheimer's disease | HP:0002511 |
| T3 | 349-362 | Phenotype | denotes | neuronal loss | HP:0002529 |
CL-cell
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 349-357 | Cell | denotes | neuronal | http://purl.obolibrary.org/obo/CL:0000540 |
| T2 | 577-591 | Cell | denotes | cultured cells | http://purl.obolibrary.org/obo/CL:0000010 |
| T3 | 877-891 | Cell | denotes | pyramidal cell | http://purl.obolibrary.org/obo/CL:0000598 |
| T4 | 1070-1074 | Cell | denotes | poly | http://purl.obolibrary.org/obo/CL:0000096|http://purl.obolibrary.org/obo/CL:0000775 |
| T6 | 1475-1483 | Cell | denotes | neuronal | http://purl.obolibrary.org/obo/CL:0000540 |
| T7 | 1484-1498 | Cell | denotes | cultured cells | http://purl.obolibrary.org/obo/CL:0000010 |